Investigating how a specific RNA affects obesity-related blood vessel aging and insulin resistance
Role of lncRNA Meg3 in obesity-induced endothelial senescence and insulin resistance
This study is looking at how a specific molecule called Meg3 affects blood vessel health and insulin resistance in people who are obese, with the hope of finding new ways to help improve insulin sensitivity and reduce the risk of diabetes and heart problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project ID | NIH-10619489 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a long non-coding RNA called Meg3 in the aging of blood vessels and insulin resistance caused by obesity. By studying how Meg3 influences cell behavior in the context of obesity, researchers aim to uncover new mechanisms that contribute to insulin resistance, which is a significant risk factor for diabetes and cardiovascular diseases. The approach involves analyzing changes in gene expression in blood vessels from obese mice and assessing the effects of reducing Meg3 levels on cell function and health. This could lead to the identification of new therapeutic targets for improving insulin sensitivity in patients with obesity.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are obese and may be experiencing insulin resistance or related metabolic issues.
Not a fit: Patients who are not obese or do not have insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve insulin sensitivity and reduce the risk of diabetes and cardiovascular diseases in obese patients.
How similar studies have performed: Other research has shown promising results in understanding the role of non-coding RNAs in metabolic diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Lincoln, United States
- University of Nebraska Lincoln — Lincoln, United States (Active)
Researchers
- Principal investigator: Sun, Xinghui — University of Nebraska Lincoln
- Study coordinator: Sun, Xinghui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.